Medco, FDA to Study Impact of Genetic Testing on Rx Efficacy | GenomeWeb
NEW YORK (GenomeWeb News) – Pharmacy benefits manager Medco Health Solutions said Monday that it has partnered with the US Food and Drug Administration to study the impact of genetic testing on the efficacy of prescription drugs.
The Franklin Lakes, NJ-based firm said that it would work with the FDA to jointly develop research projects, programs, and strategies in pharmacogenomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.